Enanta Pharma: Q4 Earnings Insights

Enanta Pharma ENTA released its Q4 earnings on Monday, November 25, 2024 at 04:01 PM.

Here's what's important from the earnings announcement.

Enanta Pharma beat estimated earnings by 4.0%, reporting an EPS of $-1.36 versus an estimate of $-1.41.

Revenue was down $4.33 million from the same period last year.

The company beat on EPS by $0.38 in the previous quarter, leading to a 1.0% increase share price change the next day.

Here's a look at Enanta Pharma's past performance:

Quarter	Q3 2024	Q2 2024	Q1 2024	Q4 2023
EPS Estimate	-1.45	-1.33	-1.19	-2
EPS Actual	-1.07	-1.47	-1.58	-1.33
Revenue Estimate	17.18M	16.52M	21.28M	17.50M
Revenue Actual	17.97M	17.05M	18.00M	18.93M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar